364 related articles for article (PubMed ID: 38590433)
1. Advanced approaches of the use of circRNAs as a replacement for cancer therapy.
Hama Faraj GS; Hussen BM; Abdullah SR; Fatih Rasul M; Hajiesmaeili Y; Baniahmad A; Taheri M
Noncoding RNA Res; 2024 Sep; 9(3):811-830. PubMed ID: 38590433
[TBL] [Abstract][Full Text] [Related]
2. Circular RNAs Acting as miRNAs' Sponges and Their Roles in Stem Cells.
Xiao J; Joseph S; Xia M; Teng F; Chen X; Huang R; Zhai L; Deng W
J Clin Med; 2022 May; 11(10):. PubMed ID: 35629034
[TBL] [Abstract][Full Text] [Related]
3. Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer.
Sarkar D; Diermeier SD
Noncoding RNA; 2021 Jan; 7(1):. PubMed ID: 33466455
[TBL] [Abstract][Full Text] [Related]
4. New insight into circRNAs: characterization, strategies, and biomedical applications.
Feng XY; Zhu SX; Pu KJ; Huang HJ; Chen YQ; Wang WT
Exp Hematol Oncol; 2023 Oct; 12(1):91. PubMed ID: 37828589
[TBL] [Abstract][Full Text] [Related]
5. Targeting circular RNAs as a therapeutic approach: current strategies and challenges.
He AT; Liu J; Li F; Yang BB
Signal Transduct Target Ther; 2021 May; 6(1):185. PubMed ID: 34016945
[TBL] [Abstract][Full Text] [Related]
6. Expanding roles of circRNAs in cardiovascular diseases.
Liu X; Yao X; Chen L
Noncoding RNA Res; 2024 Jun; 9(2):429-436. PubMed ID: 38511061
[TBL] [Abstract][Full Text] [Related]
7. Nanoplatform-Based In Vivo Gene Delivery Systems for Cancer Therapy.
Luo R; Le H; Wu Q; Gong C
Small; 2024 Mar; ():e2312153. PubMed ID: 38441386
[TBL] [Abstract][Full Text] [Related]
8. CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination.
Zhu Y; Liang L; Zhao Y; Li J; Zeng J; Yuan Y; Li N; Wu L
J Nanobiotechnology; 2024 Jan; 22(1):35. PubMed ID: 38243224
[TBL] [Abstract][Full Text] [Related]
9. CircTENM3 inhibites tumor progression via the miR-558/RUNX3 axis in prostate cancer.
Lu L; Wang F; Chen J; Zhao C; Guo S; Dong D; Jiang M; Huang Y
J Transl Med; 2023 Nov; 21(1):850. PubMed ID: 38007527
[TBL] [Abstract][Full Text] [Related]
10. A novel intronic circular RNA circFGFR1
Wang R; Zhong J; Pan X; Su Z; Xu Y; Zhang M; Chen X; Chen N; Yu T; Zhou Q
J Transl Med; 2023 Nov; 21(1):840. PubMed ID: 37993879
[TBL] [Abstract][Full Text] [Related]
11. m6A-Mediated Biogenesis of circDDIT4 Inhibits Prostate Cancer Progression by Sequestrating ELAVL1/HuR.
Kong Z; Lu Y; Yang Y; Chang K; Lin Y; Huang Y; Wang C; Zhang L; Xu W; Zhao S; Li Y
Mol Cancer Res; 2023 Dec; 21(12):1342-1355. PubMed ID: 37647111
[TBL] [Abstract][Full Text] [Related]
12. Efficient circular RNA engineering by end-to-end self-targeting and splicing reaction using
Lee KH; Kim S; Song J; Han SR; Kim JH; Lee SW
Mol Ther Nucleic Acids; 2023 Sep; 33():587-598. PubMed ID: 37637208
[TBL] [Abstract][Full Text] [Related]
13. m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.
Huang C; Xu R; Zhu X; Jiang H
Cancer Gene Ther; 2023 Oct; 30(10):1426-1440. PubMed ID: 37563361
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
